Changes in Retinal N-Acylethanolamines and their Oxylipin Derivatives During the Development of Visual Impairment in a Mouse Model for Glaucoma
- PMID: 27221132
- PMCID: PMC4911801
- DOI: 10.1007/s11745-016-4161-x
Changes in Retinal N-Acylethanolamines and their Oxylipin Derivatives During the Development of Visual Impairment in a Mouse Model for Glaucoma
Abstract
Neurons are especially susceptible to oxidative damage, which is increasingly implicated in neurodegenerative disease. Certain N-acylethanolamines (NAEs) have been shown to protect neurons from oxidative stress. Since glaucoma may be considered a neurodegenerative disorder and the survival of retinal neurons could also be influenced by N-acylethanolamines, our goal was to quantify changes in certain N-acylethanolamine species and their oxylipin derivatives in the retina of a mouse model for glaucoma. We also sought to identify relationships between these and parameters of glaucoma disease development, specifically intraocular pressure, visual acuity, and contrast sensitivity. Five N-acylethanolamine species and three NAE oxylipin derivatives were quantified in retina from young and aged DBA/2Crl mice. N-Acylethanolamines and NAE-oxylipins in retinal extracts were quantified against deuterated standards by isotope dilution gas chromatography-mass spectrometry. Levels (nmol/g dry weight) of N-arachidonoylethanolamine (anandamide; NAE 20:4) were significantly (p = 0.008) decreased in aged (2.875 ± 0.6702) compared to young animals (5.175 ± 0.971). Conversely, the anandamide oxylipin, 15(S)-HETE ethanolamide (15(S)-HETE EA), was significantly (p = 0.042) increased in aged (0.063 ± 0.009) compared to young animals (0.039 ± 0.011). Enzymatic depletion of the anandamide pool by 15-lipoxygenase and consequent accumulation of 15(S)-HETE ethanolamine may contribute to decreased visual function in glaucomatous mice. Since N-acylethanolamines effectively attenuate glaucoma pathogenesis and associated visual impairment, our data provides additional rationale and novel targets for glaucoma therapies.
Keywords: Acylethanolamides; Anandamide; Contrast sensitivity; DBA/2; Intraocular pressure; Lipoxin; Lipoxygenase; N-Linoleoylethanolamine; N-Oleylethanolamine; Neuroprotection; Optokinetic reflex; Optomotor; Visual acuity.
Figures
Similar articles
-
N-acylethanolamines are metabolized by lipoxygenase and amidohydrolase in competing pathways during cottonseed imbibition.Plant Physiol. 2002 Sep;130(1):391-401. doi: 10.1104/pp.004689. Plant Physiol. 2002. PMID: 12226518 Free PMC article.
-
Anandamide and other N-acylethanolamines in mouse peritoneal macrophages.Chem Phys Lipids. 1997 Jul 14;87(2):103-10. doi: 10.1016/s0009-3084(97)00032-7. Chem Phys Lipids. 1997. PMID: 9275307
-
Assessment of inner retina dysfunction and progressive ganglion cell loss in a mouse model of glaucoma.Exp Eye Res. 2014 May;122:40-9. doi: 10.1016/j.exer.2014.02.022. Epub 2014 Mar 12. Exp Eye Res. 2014. PMID: 24631335
-
N-Acylethanolamines: lipid metabolites with functions in plant growth and development.Plant J. 2014 Aug;79(4):568-83. doi: 10.1111/tpj.12427. Epub 2014 Feb 25. Plant J. 2014. PMID: 24397856 Review.
-
Psychophysical testing in rodent models of glaucomatous optic neuropathy.Exp Eye Res. 2015 Dec;141:154-63. doi: 10.1016/j.exer.2015.06.025. Epub 2015 Jul 2. Exp Eye Res. 2015. PMID: 26144667 Free PMC article. Review.
Cited by
-
Cannabinoids and endocannabinoids as therapeutics for nervous system disorders: preclinical models and clinical studies.Neural Regen Res. 2024 Apr;19(4):788-799. doi: 10.4103/1673-5374.382220. Neural Regen Res. 2024. PMID: 37843213 Free PMC article. Review.
-
Synergism of mechanisms underlying early-stage changes in retina function in male hyperglycemic db/db mice in the absence and presence of chemically-induced dyslipidemia.Sci Rep. 2023 Oct 13;13(1):17347. doi: 10.1038/s41598-023-44446-3. Sci Rep. 2023. PMID: 37833428 Free PMC article.
-
Novel Machine-Learning Based Framework Using Electroretinography Data for the Detection of Early-Stage Glaucoma.Front Neurosci. 2022 May 4;16:869137. doi: 10.3389/fnins.2022.869137. eCollection 2022. Front Neurosci. 2022. PMID: 35600610 Free PMC article.
-
The Contribution of Anterior Segment Abnormalities to Changes in Intraocular Pressure in the DBA/2J Mouse Model of Glaucoma: DBA/2J-Gpnmb +/SjJ Mice as Critical Controls.Front Neurosci. 2022 Feb 3;15:801184. doi: 10.3389/fnins.2021.801184. eCollection 2021. Front Neurosci. 2022. PMID: 35185449 Free PMC article.
-
Plasma Metabolomics of Intermediate and Neovascular Age-Related Macular Degeneration Patients.Cells. 2021 Nov 12;10(11):3141. doi: 10.3390/cells10113141. Cells. 2021. PMID: 34831363 Free PMC article.
References
-
- Terland O, Flatmark T, Tangeras A, Gronberg M. Dopamine oxidation generates an oxidative stress mediated by dopamine semiquinone and unrelated to reactive oxygen species. J Mol Cell Cardiol. 1997;29(6):1731–1738. - PubMed
-
- Andersen JK. Oxidative stress in neurodegeneration: cause or consequence? Nat Med. 2004;10(Suppl):S18–S25. - PubMed
-
- Ohia SE, Opere CA, Leday AM. Pharmacological consequences of oxidative stress in ocular tissues. Mutat Res. 2005;579(1–2):22–36. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
